Cancer is devastating at any age, but it’s especially difficult to watch a toddler battle this horrific disease before they’ve even had a chance to really be a kid. Unfortunately, it’s not uncommon for young children to be diagnosed with cancer and patients are often unable to fight off the disease. However, that doesn’t mean that miracles don’t happen every day. Recently one Kentucky toddler who was given a stage four diagnosis beat all the odds and is now in remission.
Molly Hughes was diagnosed with stage four neuroblastoma at only 5 months old.
Neuroblastoma is an aggressive form of cancer that typically arises in and around the adrenal glands which sit on top of the kidneys. It’s most commonly diagnosed in children age 5 or younger.
For the past 15 months, Molly has had to undergo multiple rounds ofchemo, surgery, radiation, and other intense procedures.
“I don’t think people realize until you actually go through it, just how hard it is,” said Molly’s mother, Chelsea Hughes. “With neuroblastoma, it’s so aggressive that they have to treat it that hard.”
From the beginning of her treatment, Molly was strong and didn’t let her diagnosis stop her from being a kid.
“She would just bounce back after every treatment. I mean it would knock her down for a few days, but then she’d be up playing,” said Chelsea.
At the end of January, Molly celebrated the end of five rounds of chemo and her parents were notified that the tiny toddler was finally cancer-free.
“I kinda just fell to the ground after I got off the phone and I just hugged for her like five minutes,” said Chelsea.
The 21-month-old is trading saying good-bye to her 130 nights in a hospital and beginning her cancer-free childhood. Chelsea says Molly is so full of life and is taking advantage of every moment.
“She loves being outside from the time she gets up ’til she goes to bed, she’s just wild,” said Chelsea. “So full of energy and just loves doing what a baby should be doing.”
As a result of her treatments, Molly lost partial hearing and she’ll return to the hospital Monday to start a trial drug that helps prevent relapse.